Results 151 to 160 of about 210,208 (400)

Clinical impact of follow‐up endomyocardial biopsy in myocarditis during or after immune‐suppressive therapy

open access: yesESC Heart Failure, EarlyView.
Results and clinical implication of repeat endomyocardial biopsy (EMB). Abstract Aims While the diagnostic role of endomyocardial biopsy (EMB) in myocarditis is unquestioned, little is known about its indications and clinical value during long‐term follow‐up.
Anna Baritussio   +12 more
wiley   +1 more source

Is Mitral Valve Repair Superior to Mitral Valve Replacement in Elderly Patients? Comparison of Short‐ and Long‐Term Outcomes in a Propensity‐Matched Cohort

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundBecause of demographic changes, a growing number of elderly patients present with mitral valve (MV) disease. Although mitral valve repair (MV‐repair) is the “gold standard” treatment for MV disease, in elderly patients, there is controversy ...
Miriam Silaschi   +8 more
doaj   +1 more source

Degenerative mitral valve regurgitation: best practice revolution [PDF]

open access: yes, 2010
Degenerative mitral valve disease often leads to leaflet prolapse due to chordal elongation or rupture, and resulting in mitral valve regurgitation. Guideline referral for surgical intervention centres primarily on symptoms and ventricular dysfunction ...
Adams   +82 more
core   +2 more sources

Atrial‐secondary tricuspid regurgitation: a better prognosis in early stage heart failure, but not in late stage

open access: yesESC Heart Failure, EarlyView.
Atrial TR as more favourable prognosis except in advanced patients. Abstract Background and Aims Although the classification of secondary tricuspid regurgitation (STR) by atrial or ventricular aetiology (A‐STR or V‐STR) carries prognostic importance, the confounding effects of New York Heart Association (NYHA) class have not yet been elucidated.
Corentin Bourg   +9 more
wiley   +1 more source

Economic Burden of Inpatient Care for Mitral Regurgitation in Maryland

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Mitral regurgitation (MR) is the most common valvular disease in the United States and increases the risk of death and hospitalization. The economic burden of MR in the United States is not known.
Radoslav Zinoviev   +4 more
doaj   +1 more source

Clinical impact of tricuspid regurgitation in patients with acute myocardial infarction

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post‐AMI patients treated with appropriate primary percutaneous coronary intervention (PCI).
Shun Nishino   +5 more
wiley   +1 more source

Results of surgery for irreversible moderate to severe mitral valve regurgitation secondary to myocardial infarction [PDF]

open access: yes, 2017
Objective: Moderate to severe irreversible mitral regurgitation secondary to myocardial infarction is an independent risk factor for reduced long-term survival.
Bettex, Dominique   +7 more
core  

The pulmonary artery pulsatility index in patients with severe aortic stenosis undergoing valve replacement

open access: yesESC Heart Failure, EarlyView.
Abstract Background and aims The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...
Laura A. Rechsteiner   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy